Literature DB >> 33269015

Genetic variability in sodium-glucose cotransporter 2 influences glycemic control and risk for diabetic retinopathy in type 2 diabetes patients.

Jasna Klen1, Katja Goričar2, Vita Dolžan2.   

Abstract

BACKGROUND: Gluconeogenesis and renal glucose excretion in kidneys both play an important role in glucose homeostasis. Sodium-glucose cotransporter (SGLT2), coded by the SLC5A2 gene is responsible for reabsorption up to 99% of the filtered glucose in proximal tubules. SLC5A2 genetic polymorphisms were suggested to influence glucose homeostasis. We investigated if common SLC5A2 rs9934336 polymorphism influences glycemic control and risk for macro or microvascular complications in Slovenian type 2 diabetes (T2D) patients.
METHODS: All 181 clinically well characterized T2D patients were genotyped for SLC5A2 rs9934336 G>A polymorphism. Associations with glycemic control and T2D complications were assessed with nonparametric tests and logistic regression.
RESULTS: SLC5A2 rs9934336 was significantly associated with increased fasting blood glucose levels (P<0.001) and HbA1c levels under the dominant genetic model (P=0.030). After adjustment for T2D duration, significantly higher risk for diabetic retinopathy was present in carriers of at least one polymorphic SLC5A2 rs9934336 A allele compared to non-carriers (OR=7.62; 95%CI=1.65-35.28; P=0.009).
CONCLUSIONS: Our pilot study suggests an important role of SLC5A2 polymorphisms in the physiologic process of glucose reabsorption in kidneys in T2D patients. This is also the first report on the association between SLC5A2 polymorphism and diabetic retinopathy. 2020 Jasna Klen, Katja Goričar, Vita Dolžan, published by CEON/CEES.

Entities:  

Keywords:  SGLT2; SLC5A2; diabetes type 2; genetic polymorphism; retinopathy

Year:  2020        PMID: 33269015      PMCID: PMC7682783          DOI: 10.2478/jomb-2019-0040

Source DB:  PubMed          Journal:  J Med Biochem        ISSN: 1452-8266            Impact factor:   3.402


  26 in total

1.  dbSNP: the NCBI database of genetic variation.

Authors:  S T Sherry; M H Ward; M Kholodov; J Baker; L Phan; E M Smigielski; K Sirotkin
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Renoprotective effects of sodium-glucose cotransporter-2 inhibitors.

Authors:  Hiddo J L Heerspink; Mikhail Kosiborod; Silvio E Inzucchi; David Z I Cherney
Journal:  Kidney Int       Date:  2018-05-05       Impact factor: 10.612

Review 3.  Pericytes and vascular stability.

Authors:  Desiree von Tell; Annika Armulik; Christer Betsholtz
Journal:  Exp Cell Res       Date:  2005-11-21       Impact factor: 3.905

Review 4.  Endothelial/pericyte interactions.

Authors:  Annika Armulik; Alexandra Abramsson; Christer Betsholtz
Journal:  Circ Res       Date:  2005-09-16       Impact factor: 17.367

5.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

Review 6.  Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.

Authors:  Mohammad Shamsul Ola; Mohd Imtiaz Nawaz; M Mairaj Siddiquei; Saleh Al-Amro; Ahmed M Abu El-Asrar
Journal:  J Diabetes Complications       Date:  2012-01-05       Impact factor: 2.852

7.  SGLT2 inhibitors.

Authors:  I Dardi; T Kouvatsos; S A Jabbour
Journal:  Biochem Pharmacol       Date:  2015-09-08       Impact factor: 5.858

8.  Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

Authors:  Christoph Wanner; Silvio E Inzucchi; John M Lachin; David Fitchett; Maximilian von Eynatten; Michaela Mattheus; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Bernard Zinman
Journal:  N Engl J Med       Date:  2016-06-14       Impact factor: 91.245

9.  Investigation of SLC2A1 26177A/G gene polymorphism via high resolution melting curve analysis in Malaysian patients with diabetic retinopathy.

Authors:  Zhi Xiang Ng; Umah Rani Kuppusamy; Iqbal Tajunisah; Kenneth Choong Sian Fong; Kek Heng Chua
Journal:  J Diabetes Complications       Date:  2012-07-12       Impact factor: 2.852

10.  Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells.

Authors:  Masanori Wakisaka; Tetsuhiko Nagao; Mototaka Yoshinari
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

View more
  3 in total

Review 1.  Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.

Authors:  Sejal Lahoti; Mouhamed Nashawi; Omar Sheikh; David Massop; Mahnoor Mir; Robert Chilton
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-05-18

2.  Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Bin Zhou; Yetan Shi; Rongrong Fu; Haixiang Ni; Lihu Gu; Yuexiu Si; Mengting Zhang; Ke Jiang; Jingyi Shen; Xiangyuan Li; Xing Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

Review 3.  Pharmacogenetics of new classes of antidiabetic drugs.

Authors:  Selma Imamovic Kadric; Aida Kulo Cesic; Tanja Dujic
Journal:  Bosn J Basic Med Sci       Date:  2021-12-01       Impact factor: 3.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.